Lloyd Advisory Services’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Lloyd Advisory Services’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-23,358	Closed	-$120K	–	347
2023 Q3	$120K	Buy	+23,358	New	+$110K	0.04%	250

Other funds holding AUGX

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Lloyd Advisory Services's AUGX Position: Q4 2023 in Review

Lloyd Advisory Services sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2023, closing a stake of 23,358 shares — an estimated $120K sold.

Lloyd Advisory Services first reported a position in AUGX in Q3 2023 and held it in 1 quarter. The position peaked at $120K in Q3 2023. 85 funds tracked by Wall St. Rank hold AUGX as of Q4 2023.

Lloyd Advisory Services reported no remaining Augmedix, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Lloyd Advisory Services sold 23,358 Augmedix, Inc. Common Stock shares in Q4 2023, an estimated $120K.
Lloyd Advisory Services first reported a position in Augmedix, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
Lloyd Advisory Services's Augmedix, Inc. Common Stock position peaked at $120K in Q3 2023.
85 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2023.

Based on Lloyd Advisory Services's 13F filing for Q4 2023, filed 13 Feb 2024.